Anti Suicide Drugs Market
According to Intent Market Research, the Anti-Suicide Drugs Market is expected to grow from USD 7.6 Billion in 2024-e at a CAGR of 11.2% to touch USD 14.4 Billion by 2030. The Anti-Suicide Drugs Market is dominated by key players such as Eli Lilly and Co., Johnson & Johnson, Bristol-Myers Squibb, GlaxoSmithKline, AbbVie, and AstraZeneca.